GMAB Genmab A/S

50.60USD-1.46%Mkt Cap: 31.20B USDP/E: 42.88

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with rel…